Cantor Fitzgerald Reiterates Overweight Rating on Nano-X Imaging Ltd. (NNOX)

Market Context

Nano-X Imaging Ltd. operates in the Healthcare sector. The stock currently trades at $0.92 with a market capitalization of $212.6M. The stock has declined 74.5% over the past 52 weeks.

Analyst coverage from Cantor Fitzgerald provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Nano-X Imaging Ltd.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Nano-X Imaging Ltd.

Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Aug 17, 2026	Cantor Fitzgerald	Overweight	N/A
Jul 07, 2026	Alliance Global Partners	Neutral	N/A
Apr 20, 2026	D. Boral Capital	Buy	N/A
Apr 13, 2026	D. Boral Capital	Buy	N/A
Mar 03, 2026	D. Boral Capital	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View NNOX Stock Page